<?xml version="1.0" encoding="UTF-8" ?>

<Genomics_ConceptTask>
<TEXT><![CDATA[Bcl-2 silencing attenuates hypoxia-induced apoptosis resistance in pulmonary 
microvascular endothelial cells.

Pulmonary arterial hypertension (PAH) is a life-threatening disorder that 
ultimately causes heart failure. While the underlying causes of this condition 
are not well understood, previous studies suggest that the anti-apoptotic nature 
of pulmonary microvascular endothelial cells (PMVECs) in hypoxic environments 
contributes to PAH pathogenesis. In this study, we focus on the contribution of 
Bcl-2 and hypoxia response element (HRE) to apoptosis-resistant endothelial 
cells and investigate the mechanism. PMVECs obtained from either normal rats or 
apoptosis-resistant PMVECs obtained from PAH rats were transduced with 
recombinant lentiviral vectors carrying either Bcl-2-shRNA or HRE combined 
Bcl-2-shRNA, and then cultured these cells for 24 h under hypoxic (5% O2) or 
normoxic (21% O2) conditions. In normal PMVECs, Bcl-2-shRNA or HRE combined with 
Bcl-2-shRNA transduction successfully decreased Bcl-2 expression, while 
increasing apoptosis as well as caspase-3 and P53 expression in a normoxic 
environment. In a hypoxic environment, the effects of Bcl-2-shRNA treatment on 
cell apoptosis, and on Bcl-2, caspase-3, P53 expression were significantly 
suppressed. Conversely, HRE activation combined with Bcl-2-shRNA transduction 
markedly enhanced cell apoptosis and upregulated caspase-3 and P53 expression, 
while decreasing Bcl-2 expression. Furthermore, in apoptosis-resistant PMVECs, 
HRE-mediated Bcl-2 silencing effectively enhanced cell apoptosis and caspase-3 
activity. The apoptosis rate was significantly depressed when Lv-HRE-Bcl-2-shRNA 
was combined with Lv-P53-shRNA or Lv-caspase3-shRNA transduction in a hypoxic 
environment. These results suggest that HRE-mediated Bcl-2 inhibition can 
effectively attenuate hypoxia-induced apoptosis resistance in PMVECs by 
downregulating Bcl-2 expression and upregulating caspase-3 and P53 expression. 
This study therefore reveals critical insight into potential therapeutic targets 
for treating PAH.
]]></TEXT>
<TAGS>
<PERTURBING_ACTION id="P0" spans="739~797" text="recombinant lentiviral vectors carrying either Bcl-2-shRNA" perturbingaction="rnai/knockdown" />
<PERTURBING_ACTION id="P1" spans="801~826" text="HRE combined  Bcl-2-shRNA" perturbingaction="rnai/knockdown" />
<PERTURBING_ACTION id="P2" spans="941~952" text="Bcl-2-shRNA" perturbingaction="rnai/knockdown" />
<PERTURBING_ACTION id="P3" spans="956~999" text="HRE combined with  Bcl-2-shRNA transduction" perturbingaction="rnai/knockdown" />
<PERTURBING_ACTION id="P4" spans="1178~1189" text="Bcl-2-shRNA" perturbingaction="rnai/knockdown" />
<PERTURBING_ACTION id="P5" spans="1304~1357" text="HRE activation combined with Bcl-2-shRNA transduction" perturbingaction="rnai/knockdown" />
<PERTURBING_ACTION id="P6" spans="1519~1547" text="HRE-mediated Bcl-2 silencing" perturbingaction="rnai/knockdown" />
<PERTURBING_ACTION id="P7" spans="1661~1711" text="Lv-HRE-Bcl-2-shRNA  was combined with Lv-P53-shRNA" perturbingaction="rnai/knockdown" />
<PERTURBING_ACTION id="P8" spans="1715~1745" text="Lv-caspase3-shRNA transduction" perturbingaction="rnai/knockdown" />
<PERTURBING_ACTION id="P9" spans="1800~1829" text="HRE-mediated Bcl-2 inhibition" perturbingaction="other" />
<CONTEXT id="C0" spans="623~629" text="PMVECs" context="cells" />
<CONTEXT id="C1" spans="658~662" text="rats" context="organism" />
<CONTEXT id="C2" spans="667~693" text="apoptosis-resistant PMVECs" context="cells" />
<CONTEXT id="C3" spans="708~716" text="PAH rats" context="organism" />
<CONTEXT id="C4" spans="852~857" text="cells" context="cells" />
<CONTEXT id="C5" spans="926~939" text="normal PMVECs" context="cells" />
<CONTEXT id="C6" spans="1204~1208" text="cell" context="cells" />
<CONTEXT id="C7" spans="1377~1381" text="cell" context="cells" />
<CONTEXT id="C8" spans="1490~1516" text="apoptosis-resistant PMVECs" context="cells" />
<CONTEXT id="C9" spans="1569~1573" text="cell" context="cells" />
<CONTEXT id="C10" spans="1897~1903" text="PMVECs" context="cells" />
<CONTEXT id="C12" spans="553~591" text="apoptosis-resistant endothelial  cells" context="cells" />
<PHENOTYPE id="PH0" spans="1059~1068" text="apoptosis" phenotype="apoptosis" />
<PHENOTYPE id="PH1" spans="1209~1218" text="apoptosis" phenotype="apoptosis" />
<PHENOTYPE id="PH2" spans="1382~1391" text="apoptosis" phenotype="apoptosis" />
<PHENOTYPE id="PH3" spans="1574~1583" text="apoptosis" phenotype="apoptosis" />
<PHENOTYPE id="PH4" spans="1613~1622" text="apoptosis" phenotype="apoptosis" />
<PHENOTYPE id="PH5" spans="1873~1882" text="apoptosis" phenotype="apoptosis" />
<EFFECT id="E0" spans="1048~1058" text="increasing" effect="positive" />
<EFFECT id="E1" spans="1368~1376" text="enhanced" effect="positive" />
<EFFECT id="E2" spans="1560~1568" text="enhanced" effect="positive" />
<EFFECT id="E3" spans="1646~1655" text="depressed" effect="negative" />
<EFFECT id="E4" spans="1847~1856" text="attenuate" effect="negative" />
<EFFECT id="E5" spans="1865~1872" text="induced" effect="positive" />
<EFFECT id="E6" spans="1883~1893" text="resistance" effect="negative" />
<ENTITY_LINKING id="EN0" perturbing_actionID="P5" perturbing_actionText="HRE activation combined with Bcl-2-shRNA transduction" effectID="E1" effectText="enhanced" contextID="C7" contextText="cell" phenotypeID="PH2" phenotypeText="apoptosis" />
<ENTITY_LINKING id="EN1" perturbing_actionID="P6" perturbing_actionText="HRE-mediated Bcl-2 silencing" effectID="E2" effectText="enhanced" contextID="C9" contextText="cell" phenotypeID="PH3" phenotypeText="apoptosis" />
<ENTITY_LINKING id="EN2" perturbing_actionID="P6" perturbing_actionText="HRE-mediated Bcl-2 silencing" contextID="C8" contextText="apoptosis-resistant PMVECs" effectID="E2" effectText="enhanced" phenotypeID="PH3" phenotypeText="apoptosis" />
<ENTITY_LINKING id="EN3" perturbing_actionID="P2" perturbing_actionText="Bcl-2-shRNA" contextID="C5" contextText="normal PMVECs" effectID="E0" effectText="increasing" phenotypeID="PH0" phenotypeText="apoptosis" />
<ENTITY_LINKING id="EN4" contextID="C5" contextText="normal PMVECs" perturbing_actionID="P3" perturbing_actionText="HRE combined with  Bcl-2-shRNA transduction" effectID="E0" effectText="increasing" phenotypeID="PH0" phenotypeText="apoptosis" />
</TAGS>
</Genomics_ConceptTask>